Depei Wu

576 total citations
28 papers, 313 citations indexed

About

Depei Wu is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Depei Wu has authored 28 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 16 papers in Infectious Diseases and 11 papers in Oncology. Recurrent topics in Depei Wu's work include Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (15 papers) and Neutropenia and Cancer Infections (7 papers). Depei Wu is often cited by papers focused on Antifungal resistance and susceptibility (16 papers), Fungal Infections and Studies (15 papers) and Neutropenia and Cancer Infections (7 papers). Depei Wu collaborates with scholars based in China, United States and Canada. Depei Wu's co-authors include Xiao‐Jun Huang, He Huang, Yuqian Sun, Fan‐Yi Meng, Xi Zhang, Li Yu, Hanyun Ren, Zhixiang Shen, Yu Ji and Mingzhe Han and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

Depei Wu

25 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Depei Wu China	10	194	189	85	47	34	28	313
Riva Fineman Israel	11	151 0.8×	99 0.5×	165 1.9×	23 0.5×	67 2.0×	30	501
Adam J. DiPippo United States	10	221 1.1×	180 1.0×	81 1.0×	46 1.0×	44 1.3×	23	352
Hanafy Hafez Egypt	9	36 0.2×	90 0.5×	61 0.7×	24 0.5×	34 1.0×	32	262
Angelika Valentin Austria	7	111 0.6×	125 0.7×	49 0.6×	27 0.6×	80 2.4×	12	313
Angela Haßler Germany	8	103 0.5×	225 1.2×	60 0.7×	12 0.3×	33 1.0×	9	377
Yıldız Yildirmak Türkiye	12	36 0.2×	59 0.3×	44 0.5×	17 0.4×	114 3.4×	31	326
Yutaro Hino Japan	7	165 0.9×	55 0.3×	84 1.0×	39 0.8×	117 3.4×	20	352
Melissa Hollifield United States	10	175 0.9×	315 1.7×	36 0.4×	77 1.6×	13 0.4×	13	476
Berthe‐Marie Imbert France	8	88 0.5×	100 0.5×	99 1.2×	16 0.3×	84 2.5×	16	325
Ingvill Purr Germany	5	70 0.4×	139 0.7×	113 1.3×	9 0.2×	18 0.5×	6	349

Countries citing papers authored by Depei Wu

Since Specialization

Citations

This map shows the geographic impact of Depei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Depei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Depei Wu more than expected).

Fields of papers citing papers by Depei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Depei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Depei Wu. The network helps show where Depei Wu may publish in the future.

Co-authorship network of co-authors of Depei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Depei Wu. A scholar is included among the top collaborators of Depei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Depei Wu. Depei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mo, Xiao‐Dong, He Huang, Feng Chen, et al.. (2024). A Phase II Study to Evaluate the Efficacy and Safety of Pimicotinib (ABSK021) in Chronic Graft Versus Host Disease (cGvHD) after 1 or More Lines of Systemic Treatment. Blood. 144(Supplement 1). 99–99. 1 indexed citations

Wu, Depei, et al.. (2024). Prospective Study of Avapritinib in Patients with Relapsed/Refractory or MRD-Positive Core-Binding Factor Acute Myeloid Leukemia with KIT Mutations. Blood. 144(Supplement 1). 222–222.

Sarocchi, Matteo, Junmin Li, Depei Wu, et al.. (2024). Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study. British Journal of Haematology. 204(5). 2049–2056. 3 indexed citations

Yin, Jia, Qingya Cui, Haiping Dai, et al.. (2024). Unleashing the Power of CD19 CAR-T in Relapsed AML: Findings from a Prospective Single-Center Clinical Trial. Blood. 144(Supplement 1). 4836–4836. 3 indexed citations

Wu, Yuanbing, Shanshan Jiang, Dongyang Li, et al.. (2024). Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases. Infectious Diseases and Therapy. 13(1). 141–154. 9 indexed citations

Qu, Changju, Hailing Liu, Rui Zou, et al.. (2023). P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL. HemaSphere. 7(S3). e918465b–e918465b. 1 indexed citations

Chen, Suning, et al.. (2022). Chinese expert consensus on oral drugs for the treatment of mature B-cell lymphomas (2020 edition). Frontiers of Medicine. 16(5). 815–826. 2 indexed citations

Li, Weiyang, Fan Xia, Haixia Zhou, et al.. (2020). Efficacy of Posaconazole Prophylaxis for Fungal Disease in Hematology Patients Treated With Chemotherapy and Transplantation: An Open-Label, Prospective, Observational Study. Frontiers in Microbiology. 11. 349–349. 10 indexed citations

Liu, Kai‐Yan, Depei Wu, Junmin Li, et al.. (2020). Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection. Advances in Therapy. 37(5). 2493–2506. 5 indexed citations

10.

Shen, Lei, Liang Han, Yuting Xue, et al.. (2019). Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial). Annals of Oncology. 30. v877–v877. 25 indexed citations

11.

Wang, Ling, Ying Wang, Jiong Hu, et al.. (2019). Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study. Frontiers of Medicine. 13(3). 365–377. 13 indexed citations

12.

Jin, Jie, Depei Wu, Yang Liu, et al.. (2019). Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data. BMC Infectious Diseases. 19(1). 471–471. 8 indexed citations

13.

Tang, Laura, Xiaohua Yang, Xiaoqiong Tang, et al.. (2018). Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de Mycologie Médicale. 28(2). 379–383. 17 indexed citations

14.

Hu, Jiong, Yu Hu, He Huang, et al.. (2017). Caspofungin Treatment for Pulmonary Invasive Fungal Disease in Hematology Patients: A Retrospective Study in a Clinical Practice Setting in China. Clinical Therapeutics. 39(9). 1758–1768. 2 indexed citations

15.

Zhang, Rongli, Jing Chen, He Huang, et al.. (2017). Primary fungal prophylaxis in acute leukemia patients with different risk factors: retrospective analysis from the CAESAR study. International Journal of Hematology. 106(2). 221–228. 6 indexed citations

16.

Wang, Ling, Jiong Hu, Yuqian Sun, et al.. (2016). Does High-Dose Cytarabine Cause More Fungal Infection in Patients With Acute Myeloid Leukemia Undergoing Consolidation Therapy. Medicine. 95(4). e2560–e2560. 10 indexed citations

17.

Gao, Lei, Yuqian Sun, Fan‐Yi Meng, et al.. (2016). Antifungal prophylaxis of patients undergoing allogenetic hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Journal of Hematology & Oncology. 9(1). 97–97. 20 indexed citations

18.

Sun, Yuqian, Fan‐Yi Meng, Mingzhe Han, et al.. (2015). Epidemiology, Management, and Outcome of Invasive Fungal Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation in China: A Multicenter Prospective Observational Study. Biology of Blood and Marrow Transplantation. 21(6). 1117–1126. 75 indexed citations

19.

Chen, Guodong, Xin Xu, Jiefei Tong, et al.. (2014). Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues. The International Journal of Biochemistry & Cell Biology. 57. 157–166. 28 indexed citations

20.

Shen, Yang, Xiao‐Jun Huang, Jianxiang Wang, et al.. (2013). Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study. International Journal of Clinical Pharmacology and Therapeutics. 51(9). 738–745. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact